Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view

doi:10.1007/s40618-020-01325-2

. 2021 Apr;44(4):873-875.

doi: 10.1007/s40618-020-01325-2. Epub 2020 Jun 8.

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view

A M Berton¹, N Prencipe¹, R Giordano², E Ghigo¹, S Grottoli³

Affiliations

¹ Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy.
² Department of Biological and Clinical Sciences, University of Turin, Turin, Italy.
³ Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy. silvia.grottoli@unito.it.

PMID: 32514902
PMCID: PMC7279635
DOI: 10.1007/s40618-020-01325-2

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view

A M Berton et al. J Endocrinol Invest. 2021 Apr.

. 2021 Apr;44(4):873-875.

doi: 10.1007/s40618-020-01325-2. Epub 2020 Jun 8.

Authors

A M Berton¹, N Prencipe¹, R Giordano², E Ghigo¹, S Grottoli³

Affiliations

¹ Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy.
² Department of Biological and Clinical Sciences, University of Turin, Turin, Italy.
³ Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy. silvia.grottoli@unito.it.

PMID: 32514902
PMCID: PMC7279635
DOI: 10.1007/s40618-020-01325-2

No abstract available

Keywords: ARDS; Adrenal insufficiency; Coronavirus; Glucocorticoids; Septic shock; Viral pneumonia.

PubMed Disclaimer

Conflict of interest statement

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Cited by

Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
Matsumura K, Toyoda Y, Matsumoto S, Kawai Y, Mori T, Omasa K, Fukada T, Yamada M, Kazamaki T, Furugori S, Hiroe N, Senoo S, Shimizu M, Funabiki T, Yamazaki M. Matsumura K, et al. Am J Case Rep. 2020 Aug 19;21:e926835. doi: 10.12659/AJCR.926835. Am J Case Rep. 2020. PMID: 32811804 Free PMC article.
Real-world evidence of the use of glucocorticoids for severe COVID-19.
Albarrán-Sánchez A, Ramírez-Rentería C, Mercado M, Sánchez-García M, de Jesús Barrientos-Flores C, Ferreira-Hermosillo A. Albarrán-Sánchez A, et al. Ther Adv Endocrinol Metab. 2022 Jan 19;13:20420188211072704. doi: 10.1177/20420188211072704. eCollection 2022. Ther Adv Endocrinol Metab. 2022. PMID: 35070258 Free PMC article.
A case of shock after 10 days systemic corticosteroid therapy for COVID-19.
Uemura K, Inoue S, Kawaguchi M. Uemura K, et al. JA Clin Rep. 2021 Jan 8;7(1):7. doi: 10.1186/s40981-020-00410-y. JA Clin Rep. 2021. PMID: 33417058 Free PMC article. No abstract available.
Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C).
Kuypers FA, Rostad CA, Anderson EJ, Chahroudi A, Jaggi P, Wrammert J, Mantus G, Basu R, Harris F, Hanberry B, Camacho-Gonzalez A, Manoranjithan S, Vos M, Brown LA, Morris CR. Kuypers FA, et al. Exp Biol Med (Maywood). 2021 Dec;246(23):2543-2552. doi: 10.1177/15353702211028560. Epub 2021 Jul 13. Exp Biol Med (Maywood). 2021. PMID: 34255566 Free PMC article.
Issues for the management of people with diabetes and COVID-19 in ICU.
Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, Schnell O, Škrha J, Valensi P; “Diabetes and Cardiovascular Disease (D&CVD)” Study Group of the European Association for the Study of Diabetes (EASD). Ceriello A, et al. Cardiovasc Diabetol. 2020 Jul 20;19(1):114. doi: 10.1186/s12933-020-01089-2. Cardiovasc Diabetol. 2020. PMID: 32690029 Free PMC article. Review.

See all "Cited by" articles

References

1. WHO (2020) Clinical management of severe acute respiratory infection when COVID-19 is suspected. https://www.who.int/publications-detail/clinical-management-of-severe-ac.... Accessed 21 May 2020.
1. Shang L, Zhao J, Hu Y, et al. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395:683–684. doi: 10.1016/S0140-6736(20)30361-5. - DOI - PMC - PubMed
1. Lewis SR, Pritchard MW, Thomas CM, Smith AF. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev. 2019 doi: 10.1002/14651858.CD004477.pub3. - DOI - PMC - PubMed
1. Isidori AM, Arnaldi G, Boscaro M, et al. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency. J Endocrinol Invest. 2020 doi: 10.1007/s40618-020-01266-w. - DOI - PMC - PubMed
1. Villar J, Ferrando C, Martínez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8:267–276. doi: 10.1016/S2213-2600(19)30417-5. - DOI - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] WHO (2020) Clinical management of severe acute respiratory infection when COVID-19 is suspected. https://www.who.int/publications-detail/clinical-management-of-severe-ac.... Accessed 21 May 2020.

[2] WHO (2020) Clinical management of severe acute respiratory infection when COVID-19 is suspected. https://www.who.int/publications-detail/clinical-management-of-severe-ac.... Accessed 21 May 2020.

[3] Shang L, Zhao J, Hu Y, et al. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395:683–684. doi: 10.1016/S0140-6736(20)30361-5. - DOI - PMC - PubMed

[4] Shang L, Zhao J, Hu Y, et al. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395:683–684. doi: 10.1016/S0140-6736(20)30361-5. - DOI - PMC - PubMed

[5] Lewis SR, Pritchard MW, Thomas CM, Smith AF. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev. 2019 doi: 10.1002/14651858.CD004477.pub3. - DOI - PMC - PubMed

[6] Lewis SR, Pritchard MW, Thomas CM, Smith AF. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev. 2019 doi: 10.1002/14651858.CD004477.pub3. - DOI - PMC - PubMed

[7] Isidori AM, Arnaldi G, Boscaro M, et al. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency. J Endocrinol Invest. 2020 doi: 10.1007/s40618-020-01266-w. - DOI - PMC - PubMed

[8] Isidori AM, Arnaldi G, Boscaro M, et al. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency. J Endocrinol Invest. 2020 doi: 10.1007/s40618-020-01266-w. - DOI - PMC - PubMed

[9] Villar J, Ferrando C, Martínez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8:267–276. doi: 10.1016/S2213-2600(19)30417-5. - DOI - PubMed

[10] Villar J, Ferrando C, Martínez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8:267–276. doi: 10.1016/S2213-2600(19)30417-5. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view

Affiliations

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous